Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2021-11-24 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
康泰医学系统（秦皇岛）股份有限公司最近三年的财务报告及其审计报告以及最近一期的财务报告（2021年三季度财务数据更新版）
Annual Report Classification · 95% confidence The document is a detailed financial disclosure from 康泰医学系统 (秦皇岛) 股份有限公司 covering multiple years (2017, 2018, 2019). It includes extensive notes on accounting policies, financial instruments, impairment, credit risk, consolidation scope, and other detailed financial statement notes. The content is consistent with the notes to consolidated financial statements typically found in an Annual Report. The document is lengthy (15,000 characters) and contains substantive financial data and accounting policies, not just an announcement or summary. There is no indication that this is a certification, announcement, or a partial report like an interim or quarterly report. Therefore, it fits the definition of an Annual Report (10-K) or equivalent comprehensive yearly financial report. FY 2019
2021-11-24 Chinese
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转债并在创业板上市之上市保荐书（修订稿）
Capital/Financing Update Classification · 95% confidence The document is titled as a "上市保荐书" which translates to "Securities Listing Sponsorship Letter" issued by a sponsoring institution (中信建投证券股份有限公司) regarding 康泰医学系统（秦皇岛）股份有限公司's issuance of convertible bonds and listing on the Growth Enterprise Market (创业板). The content includes detailed company background, financial data, risk factors, and regulatory compliance statements. It is a comprehensive sponsorship document related to a securities issuance and listing process, not a typical financial report like an annual or quarterly report. It is not an announcement of a report but a substantive document supporting a capital market transaction. This fits best under the category of Capital/Financing Update (CAP), as it relates to the issuance of convertible bonds and listing sponsorship. The document length (15,000 characters) and detailed financial and risk disclosures confirm it is a full report, not a brief announcement or certification. Therefore, the classification is CAP with high confidence.
2021-11-24 Chinese
北京市长安律师事务所关于康泰医学系统（秦皇岛）股份有限公司向不特定对象发行可转换公司债券之补充法律意见书（一）
Audit Report / Information Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding a company's issuance of convertible bonds to unspecified investors. It includes extensive legal analysis, regulatory compliance checks, and responses to regulatory inquiry letters related to the bond issuance. The content focuses on legal opinions, regulatory compliance, and detailed legal due diligence rather than financial results, management changes, or shareholder votes. It is not an annual report, earnings release, or management discussion. The document is a standalone legal audit-type report related to regulatory compliance and legal due diligence for a financing activity. Therefore, it fits best under the category of Audit Report / Information (AR). 9M 2021
2021-11-24 Chinese
北京市长安律师事务所关于康泰医学系统（秦皇岛）股份有限公司是否违反《国务院反垄断委员会关于平台经济领域的反垄断指南》等相关文件规定的专项核查意见
Regulatory Filings Classification · 95% confidence The document is a legal opinion issued by a law firm (北京市长安律师事务所) regarding whether 康泰医学系统（秦皇岛）股份有限公司 violated the anti-monopoly guidelines issued by the State Council Anti-Monopoly Committee concerning platform economy. The document includes detailed legal analysis, references to relevant laws and regulations, and concludes that the company did not violate the anti-monopoly laws. It is a specialized legal compliance report related to a financing event (issuance of convertible bonds) but does not contain financial statements or typical financial report content. It is not an annual or interim financial report, earnings release, or audit report. It is a standalone legal opinion on regulatory compliance, specifically an anti-monopoly compliance check. This fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories. The document length (7406 characters) and content confirm it is not a mere announcement but a substantive legal opinion, yet it is not a financial report or management report. Therefore, the classification is RNS with high confidence.
2021-11-24 Chinese
2021年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '康泰医学系统（秦皇岛）股份有限公司 2021 年第三季度报告', which translates to 'Kangtai Medical System (Qinhuangdao) Co., Ltd. 2021 Third Quarter Report'. It contains detailed financial data including balance sheets, income statements, cash flow statements, and explanations of financial changes for the third quarter of 2021. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis for a period shorter than a full fiscal year. It also mentions that the report is unaudited, which is common for interim or quarterly reports. There is no indication that this is an announcement of a report or a certification document. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). 9M 2021
2021-10-28 Chinese
关于2021年第三季度报告披露的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (426 characters) regarding the disclosure of the company's 2021 third quarter report. It states that the report was approved by the board and is available on the official disclosure website. The document itself does not contain the financial data or the report but is notifying investors about the report's availability. According to the 'Menu vs Meal' rule, such a short notice announcing the publication of a report is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2021-10-28 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.